Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 2,912 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Event Clear all

Conditions: Cancer
Interventions: FACE, Standard of Care (SOC) Control; Behavioral
Lead sponsor: Maureen Lyon; Other
Eligibility: 14 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Anxiety
Interventions: attention bias modification for anxiety; Behavioral
Lead sponsor: Hunter College of City University of New York; Other
Eligibility: 18 Years to 40 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Medication Errors, Patient Safety
Interventions: Safety Action Feedback and Engagement (SAFE) Loop; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: Not listed
Enrollment: 5,163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiogenic Shock, Heart Failure, Inflammation
Interventions: Methylprednisone, Standard of Care (SOC); Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Lymphoma Cancer, Gynecological Cancers
Interventions: group intervention and questionnaires, individual phone intervention and questionnaires, expressive writing (arm will not be include in the randomization); Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 70 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2025
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Solid Tumor
Interventions: 5-ALA; Drug
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pancreatitis, Acute
Interventions: Pirfenidone Oral Tablet, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Rochester, Minnesota

Conditions: Posttraumatic Stress Disorder (PTSD), Trauma Exposure
Interventions: Repeated imaginal exposure: Script Driven Imagery (SDI) task; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 14 Years to 18 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Diabetes Type II
Interventions: Low Carbohydrate Diet, American Diabetes Association Diet, Mindfulness and Positive Affect Skills; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: Enzalutamide during Lead-in Period, Lead-in Enzalutamide followed by Radium-223/Enzalutamide, Lead-in Enzalutamide followed by Placebo/Enzalutamide, Darolutamide during Lead-in Period, Lead-in Darolutamide followed by Radium-223/Darolutamide, Lead-in Darolutamide followed by Placebo/Darolutamide; Drug
Lead sponsor: MANA RBM; Other
Eligibility: 18 Years and older · Male only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Myrtle Beach, South Carolina

Conditions: Hypoxic-Ischemic Encephalopathy, HIE, Neurodevelopment, Infant Development
Interventions: Metformin; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 3 Months to 6 Months
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Urinary Dysfunction, Lower Urinary Tract Symptoms, Urinary Tract Infections, Urinary Tract Infections in Children
Interventions: Bladder Health Education; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 5 Years to 10 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2028 – 2033
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Airway Management
Interventions: general endotracheal anesthesia, deep sedation without endotracheal intubation; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting
Interventions: Oral Fluoroquinolones (FQ), Other Antibiotics, Febrile Illness Not Treated with Antibiotics Will be Analyzed as an Exposure; Drug · Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: Not listed
Enrollment: 117,911 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Titusville, New Jersey

Conditions: Muscle-invasive Bladder Cancer
Interventions: Atezolizumab, Placebo, Signatera; Drug · Other · Device
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 761 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Rockledge, Florida • Cleveland, Ohio • Pittsburgh, Pennsylvania

Conditions: Depression
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alcohol Abuse
Interventions: Family Check Up, Psychoeducation; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Parkinsons Disease
Interventions: Deep Brain Stimulation; Device
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Pain
Interventions: Fentanyl Buccal Tablet, Immediate release oxycodone; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 50
States / cities: Birmingham, Alabama • Mobile, Alabama • Beverly Hills, California + 45 more

Conditions: Pancreatic Cancer
Interventions: Measurement of Transitions in Cancer Scale (MOT-CA) Survey, Distress Thermometer Survey; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Ovarian Cancer
Interventions: Bendamustine HCL; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Child Development
Interventions: Parenting group; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 547 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2013
U.S. locations: 2
States / cities: Los Angeles, California • Miami, Florida

Conditions: Acute Myeloid Leukemia (AML)
Interventions: Midostaurin, Placebo, Chemotherapy; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Chicago, Illinois • Boston, Massachusetts • Portland, Oregon

Conditions: Generalized Anxiety Disorder (GAD)
Interventions: ABBV-932, Placebo for ABBV-932, Antidepressant Therapy (ADT); Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 49
States / cities: Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 43 more

Search by objective public record fields.

FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer

Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers

Safety Action Feedback and Engagement (SAFE) Loop

CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

Phase I Study in Advanced Malignancies With 5-ALA

Safety and Tolerability of Pirfenidone in Acute Pancreatitis

Predictors & Mechanisms of Adolescent PTSD

A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics

A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients

A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury

School-Based Bladder Health Intervention

Patient Positioning and Airway Management During ERCP

A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression

Family Check-Up for Adolescents and Siblings

A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

A Study of the Life Changes Experienced by Patients With Pancreatic Cancer

Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer

Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder